King Minos hall III
King Minos hall III
General assembly
Διαλειμα - Καφές
Clinical Nephrology
N.3A. Cardiovascular morbidity in CKD
1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias
2. HIF inhibitors: their place in clinical practice Athena Gompou
3. Update in the management of hyperkalaemia Evdokia Efthymiou
N.3B. Renal dietetics
1. TBC
2. TBC
3. TBC
General assembly
Clinical Nephrology
N.4A. IgA nephropathy
1. The role of B cells and BAFF/APRIL Dimitrios Bakoulis
2. New and emerging therapies in IgA nephropathy Panagiotis Kompotiatis
3. How should I manage the patient with IgA nephropathy Maria Stangou
Διαλειμμα - Καφές
Cardiovascular morbidity
N.6A. Hypertension
1. Management of hypertension in patients with CKD Georgios Hatzivasiliou
2. Resistant hypertension Vasileios Raptis
3. Use of diuretics in CKD: benefits and risks Eleni Intzevidou
4. Hypertension in dialysis Antonios Zagorianakos
Διαλειμμα - Καφές
Cardiovascular morbidity
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Cardiovascular morbidity
N.3A. Cardiovascular morbidity in CKD
1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias
2. HIF inhibitors: their place in clinical practice Athena Gompou
3. Update in the management of hyperkalaemia Evdokia Efthymiou
Close
Approved by:
Accreditation: